Mark Edmunds
Blood Banking & Transfusion Medicine West Hollywood, CA Medical Doctor
NPI 1073818548 CMS profile 479658
8700 Beverly Blvd, South Tower, Room 1670, West Hollywood, CA 90048
General payments
$43
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$38,321
Through program year 2022, Mark Edmunds of West Hollywood, CA is reported in the CMS Open Payments database as having received $43 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $38,321 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 12th percentile of Blood Banking & Transfusion Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $43 | 1 |
Beside peers
- Mark Edmunds
- Blood Banking & Transfusion Medicine median
- Middle half of Blood Banking & Transfusion Medicine
- National median
In program year 2025, general payments to Mark Edmunds were reported at $0. Among 109 Blood Banking & Transfusion Medicine profiles paid that year, the median was $146 and the middle half received between $63 and $2,018.
Show as a table
| Year | Mark Edmunds | Blood Banking & Transfusion Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $125 | $48–$2,312 | $163 |
| 2020 | $0 | $759 | $90–$20,131 | $114 |
| 2021 | $0 | $1,000 | $95–$13,211 | $132 |
| 2022 | $43 | $260 | $66–$4,567 | $149 |
| 2023 | $0 | $201 | $62–$2,687 | $160 |
| 2024 | $0 | $150 | $42–$2,468 | $164 |
| 2025 | $0 | $146 | $63–$2,018 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Blood Banking & Transfusion Medicine in California
Huy Pham
Blood Banking & Transfusion Medicine · Los Angeles, CA
Gagan Mathur
Blood Banking & Transfusion Medicine · Orange, CA
Grace Monis
Blood Banking & Transfusion Medicine · Sacramento, CA
Jennifer Woo
Blood Banking & Transfusion Medicine · Irvine, CA
Jesse Qiao
Blood Banking & Transfusion Medicine · Orange, CA
Neil Shah
Blood Banking & Transfusion Medicine · Stanford, CA
Related records
Blood Banking & Transfusion Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Blood Banking & Transfusion Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.